Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology

Neurobiology of Aging

Volumn 42, Issue , 2016, Pages 1-12

  Scheff, Stephen W ^a   Ansari, Mubeen A ^a   Mufson, Elliott J ^b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Aging; Amyloid; Dementia; Hippocampus; Neurodegeneration; Synapses; Temporal lobe

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; CARBONYL DERIVATIVE; DREBRIN; MARKER; POSTSYNAPTIC DENSITY PROTEIN 95; SYNAPSE ASSOCIATED PROTEIN 97; SYNAPSIN I; SYNAPTIC PROTEIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); NERVE PROTEIN; PEPTIDE FRAGMENT;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MILD COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; COGNITION; GENETICS; GENOTYPE; LIPID PEROXIDATION; METABOLISM; PATHOLOGY; PSYCHOLOGY; SYNAPSE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; APOLIPOPROTEINS E; COGNITION; FEMALE; GENOTYPE; HIPPOCAMPUS; HUMANS; LIPID PEROXIDATION; MALE; NERVE TISSUE PROTEINS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; SYNAPSES;

EID: 84962304626     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2016.02.030     Document Type: Article

References (130)

1. Aksenov M.Y., Aksenova M.V., Butterfield D.A., Geddes J.W., Markesbery W.R. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 2001, 103:373-383.
2. Ansari M.A., Roberts K.N., Scheff S.W. A time course of contusion-induced oxidative stress and synaptic proteins in cortex in a rat model of TBI. J. Neurotrauma 2008, 25:513-526.
3. Ansari M.A., Roberts K.N., Scheff S.W. Oxidative stress and modification of synaptic proteins in hippocampus after traumatic brain injury. Free Radic. Biol. Med. 2008, 45:443-452.
4. Ansari M.A., Scheff S.W. Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J. Neuropathol. Exp. Neurol. 2010, 69:155-167.
5. Ansari M.A., Scheff S.W. NADPH-oxidase activation and cognition in Alzheimer disease progression. Free Radic. Biol. Med. 2011, 51:171-178.
6. Arai T., Ikeda K., Akiyama H., Shikamoto Y., Tsuchiya K., Yagishita S., Beach T., Rogers J., Schwab C., McGeer P.L. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol. 2001, 101:167-173.
7. Arriagada P.V., Marzloff K., Hyman B.T. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992, 42:1681-1688.
8. Beach T.G., Sue L., Scott S., Layne K., Newell A., Walker D., Baker M., Sahara N., Yen S.H., Hutton M., Caselli R., Adler C., Connor D., Sabbagh M. Hippocampal sclerosis dementia with tauopathy. Brain Pathol. 2003, 13:263-278.
9. Bennett D.A., Schneider J.A., Arvanitakis Z., Kelly J.F., Aggarwal N.T., Shah R.C., Wilson R.S. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006, 66:1837-1844.
10. Bennett D.A., Wilson R.S., Schneider J.A., Evans D.A., Beckett L.A., Aggarwal N.T., Barnes L.L., Fox J.H., Bach J. Natural history of mild cognitive impairment in older persons. Neurology 2002, 59:198-205.
11. Bennett D.A., Yu L., Yang J., Srivastava G.P., Aubin C., De Jager P.L. Epigenomics of Alzheimer's disease. Transl. Res. 2015, 165:200-220.
12. Berchtold N.C., Coleman P.D., Cribbs D.H., Rogers J., Gillen D.L., Cotman C.W. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease. Neurobiol. Aging 2013, 34:1653-1661.
13. Berchtold N.C., Sabbagh M.N., Beach T.G., Kim R.C., Cribbs D.H., Cotman C.W. Brain gene expression patterns differentiate mild cognitive impairment from normal aged and Alzheimer's disease. Neurobiol. Aging 2014, 35:1961-1972.
14. Bereiter-Hahn J. Mitochondrial dynamics in aging and disease. Prog. Mol. Biol. Transl. Sci. 2014, 127:93-131.
15. Bouras C., Hof P.R., Giannakopoulos P., Michel J.P., Morrison J.H. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of elderly patients: a quantitative evaluation of a one-year autopsy population from a geriatric hospital. Cereb. Cortex 1994, 4:138-150.
16. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
17. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 1995, 16:271-278. discussion 8-84.
18. Brat D.J., Gearing M., Goldthwaite P.T., Wainer B.H., Burger P.C. Tau-associated neuropathology in ganglion cell tumours increases with patient age but appears unrelated to ApoE genotype. Neuropathol. Appl. Neurobiol. 2001, 27:197-205.
19. Buee L., Bussiere T., Buee-Scherrer V., Delacourte A., Hof P.R. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 2000, 33:95-130.
20. Butterfield D.A., Reed T., Perluigi M., De Marco C., Coccia R., Cini C., Sultana R. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci. Lett. 2006, 397:170-173.
21. Cahill-Smith S., Li J.M. Oxidative stress, redox signalling and endothelial dysfunction in ageing-related neurodegenerative diseases: a role of NADPH oxidase 2. Br. J. Clin. Pharmacol. 2014, 78:441-453.
22. Cairns N.J., Bigio E.H., Mackenzie I.R., Neumann M., Lee V.M., Hatanpaa K.J., White C.L., Schneider J.A., Grinberg L.T., Halliday G., Duyckaerts C., Lowe J.S., Holm I.E., Tolnay M., Okamoto K., Yokoo H., Murayama S., Woulfe J., Munoz D.G., Dickson D.W., Ince P.G., Trojanowski J.Q., Mann D.M. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007, 114:5-22. Consortium for Frontotemporal Lobar, D.
23. Calkins M.J., Manczak M., Mao P., Shirendeb U., Reddy P.H. Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum. Mol. Genet. 2011, 20:4515-4529.
24. Casley C.S., Canevari L., Land J.M., Clark J.B., Sharpe M.A. Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 2002, 80:91-100.
25. Cheng L., Yin W.J., Zhang J.F., Qi J.S. Amyloid beta-protein fragments 25-35 and 31-35 potentiate long-term depression in hippocampal CA1 region of rats in vivo. Synapse 2009, 63:206-214.
26. Coleman P.D., Yao P.J. Synaptic slaughter in Alzheimer's disease. Neurobiol. Aging 2003, 24:1023-1027.
27. Corey-Bloom J., Sabbagh M.N., Bondi M.W., Hansen L., Alford M.F., Masliah E., Thal L.J. Hippocampal sclerosis contributes to dementia in the elderly. Neurology 1997, 48:154-160.
28. Counts S.E., He B., Nadeem M., Wuu J., Scheff S.W., Mufson E.J. Hippocampal drebrin loss in mild cognitive impairment. Neurodegener. Dis. 2012, 10:216-219.
29. Crystal H., Dickson D., Fuld P., Masur D., Scott R., Mehler M., Masdeu J., Kawas C., Aronson M., Wolfson L. Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease. Neurology 1988, 38:1682-1687.
30. Dalle-Donne I., Rossi R., Giustarini D., Milzani A., Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clin. Chim. Acta 2003, 329:23-38.
31. Darwish R.S., Amiridze N., Aarabi B. Nitrotyrosine as an oxidative stress marker: evidence for involvement in neurologic outcome in human traumatic brain injury. J. Trauma 2007, 63:439-442.
32. Davis D.G., Schmitt F.A., Wekstein D.R., Markesbery W.R. Alzheimer neuropathologic alterations in aged cognitively normal subjects. J. Neuropathol. Exp. Neurol. 1999, 58:376-388.
33. DeKosky S.T., Ikonomovic M.D., Styren S.D., Beckett L., Wisniewski S., Bennett D.A., Cochran E.J., Kordower J.H., Mufson E.J. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann. Neurol. 2002, 51:145-155.
34. DeKosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann. Neurol. 1990, 27:457-464.
35. Dhillon V.S., Fenech M. Mutations that affect mitochondrial functions and their association with neurodegenerative diseases. Mutat. Res. Rev. Mutat. Res. 2014, 759:1-13.
36. Dickson D.W., Crystal H.A., Mattiace L.A., Masur D.M., Blau A.D., Davies P., Yen S.H., Aronson M.K. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging 1992, 13:179-189.
37. Dickson D.W., Davies P., Bevona C., Van Hoeven K.H., Factor S.M., Grober E., Aronson M.K., Crystal H.A. Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans. Acta Neuropathol. 1994, 88:212-221.
38. Dickson D.W., Kouri N., Murray M.E., Josephs K.A. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J. Mol. Neurosci. 2011, 45:384-389.
39. Du H., Guo L., Yan S., Sosunov A.A., McKhann G.M., Yan S.S. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:18670-18675.
40. Fariss M.W., Chan C.B., Patel M., Van Houten B., Orrenius S. Role of mitochondria in toxic oxidative stress. Mol. Interv. 2005, 5:94-111.
41. Galvin J.E., Powlishta K.K., Wilkins K., McKeel D.W., Xiong C., Grant E., Storandt M., Morris J.C. Predictors of preclinical Alzheimer disease and dementia: a clinicopathologic study. Arch. Neurol. 2005, 62:758-765.
42. Gao H.M., Zhou H., Hong J.S. NADPH oxidases: novel therapeutic targets for neurodegenerative diseases. Trends Pharmacol. Sci. 2012, 33:295-303.
43. Geser F., Robinson J.L., Malunda J.A., Xie S.X., Clark C.M., Kwong L.K., Moberg P.J., Moore E.M., Van Deerlin V.M., Lee V.M., Arnold S.E., Trojanowski J.Q. Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness. Arch. Neurol. 2010, 67:1238-1250.
44. Gibson G.E., Starkov A., Blass J.P., Ratan R.R., Beal M.F. Cause and consequence: mitochondrial dysfunction initiates and propagates neuronal dysfunction, neuronal death and behavioral abnormalities in age-associated neurodegenerative diseases. Biochim. Biophys. Acta 2010, 1802:122-134.
45. Gillardon F., Rist W., Kussmaul L., Vogel J., Berg M., Danzer K., Kraut N., Hengerer B. Proteomic and functional alterations in brain mitochondria from Tg2576 mice occur before amyloid plaque deposition. Proteomics 2007, 7:605-616.
46. Goedert M. Tau protein and neurodegeneration. Semin. Cell Dev. Biol. 2004, 15:45-49.
47. Haroutunian V., Perl D.P., Purohit D.P., Marin D., Khan K., Lantz M., Davis K.L., Mohs R.C. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch. Neurol. 1998, 55:1185-1191.
48. Hayter A.J. The maximum familywise error rate of Fisher's least significant difference test. J. Am. Stat. Assoc. 1986, 81:1000-1004.
49. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S.P., Wu J.F., Carney J.M, Lovell M., Markesbery W.R., Butterfield D.A. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 1995, 65:2146-2156.
50. Hroudova J., Singh N., Fisar Z. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease. Biomed. Res. Int. 2014, 2014:175062.
51. Hulette C.M., Welsh-Bohmer K.A., Murray M.G., Saunders A.M., Mash D.C., McIntyre L.M. Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals. J. Neuropathol. Exp. Neurol. 1998, 57:1168-1174.
52. Ighodaro E.T., Jicha G.A., Schmitt F.A., Neltner J.H., Abner E.L., Kryscio R.J., Smith C.D., Duplessis T., Anderson S., Patel E., Bachstetter A., Van Eldik L.J., Nelson P.T. Hippocampal sclerosis of aging can be segmental: two cases and review of the literature. J. Neuropathol. Exp. Neurol. 2015, 74:642-652.
53. Jellinger K.A., Alafuzoff I., Attems J., Beach T.G., Cairns N.J., Crary J.F., Dickson D.W., Hof P.R., Hyman B.T., Jack C.R., Jicha G.A., Knopman D.S., Kovacs G.G., Mackenzie I.R., Masliah E., Montine T.J., Nelson P.T., Schmitt F., Schneider J.A., Serrano-Pozo A., Thal D.R., Toledo J.B., Trojanowski J.Q., Troncoso J.C., Vonsattel J.P., Wisniewski T. PART, a distinct tauopathy, different from classical sporadic Alzheimer disease. Acta Neuropathol. 2015, 129:757-762.
54. Jellinger K.A., Attems J. Neuropathology and general autopsy findings in nondemented aged subjects. Clin. Neuropathol. 2012, 31:87-98.
55. Kamat P.K., Kalani A., Rai S., Swarnkar S., Tota S., Nath C., Tyagi N. Mechanism of oxidative stress and synapse dysfunction in the pathogenesis of Alzheimer's disease: understanding the therapeutics strategies. Mol. Neurobiol. 2014, 53:648-661.
56. Katzman R., Terry R., DeTeresa R., Brown T., Davies P., Fuld P., Renbing X., Peck A. Clinical, pathological, and neurochemical changes in dementia: a subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 1988, 23:138-144.
57. Keller J.N., Schmitt F.A., Scheff S.W., Ding Q., Chen Q., Butterfield D.A., Markesbery W.R. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005, 64:1152-1156.
58. Knopman D.S., Parisi J.E., Salviati A., Floriach-Robert M., Boeve B.F., Ivnik R.J., Smith G.E., Dickson D.W., Johnson K.A., Petersen L.E., McDonald W.C., Braak H., Petersen R.C. Neuropathology of cognitively normal elderly. J. Neuropathol. Exp. Neurol. 2003, 62:1087-1095.
59. Lardenoije R., Iatrou A., Kenis G., Kompotis K., Steinbusch H.W., Mastroeni D., Coleman P., Lemere C.A., Hof P.R., van den Hove D.L., Rutten B.P. The epigenetics of aging and neurodegeneration. Prog. Neurobiol. 2015, 131:21-64.
60. Li J.Q., Yu J.T., Jiang T., Tan L. Endoplasmic reticulum dysfunction in Alzheimer's disease. Mol. Neurobiol. 2015, 51:383-395.
61. Li S., Shankar G.M., Selkoe D.J. How do soluble oligomers of amyloid beta-protein impair hippocampal synaptic plasticity?. Front. Cell. Neurosci. 2010, 4:5.
62. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 1995, 45:1594-1601.
63. Luque-Contreras D., Carvajal K., Toral-Rios D., Franco-Bocanegra D., Campos-Pena V. Oxidative stress and metabolic syndrome: cause or consequence of Alzheimer's disease?. Oxid. Med. Cell. Longev. 2014, 2014:497802.
64. Markesbery W.R., Kryscio R.J., Lovell M.A., Morrow J.D. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann. Neurol. 2005, 58:730-735.
65. Markesbery W.R., Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging 1998, 19:33-36.
66. Markesbery W.R., Schmitt F.A., Kryscio R.J., Davis D.G., Smith C.D., Wekstein D.R. Neuropathologic substrate of mild cognitive impairment. Arch. Neurol. 2006, 63:38-46.
67. Mastroeni D., Delvaux E., Nolz J., Tan Y., Grover A., Oddo S., Coleman P.D. Aberrant intracellular localization of H3k4me3 demonstrates an early epigenetic phenomenon in Alzheimer's disease. Neurobiol. Aging 2015, 36:3121-3129.
68. Mastroeni D., Grover A., Delvaux E., Whiteside C., Coleman P.D., Rogers J. Epigenetic changes in Alzheimer's disease: decrements in DNA methylation. Neurobiol. Aging 2010, 31:2025-2037.
69. Mastroeni D., Grover A., Delvaux E., Whiteside C., Coleman P.D., Rogers J. Epigenetic mechanisms in Alzheimer's disease. Neurobiol. Aging 2011, 32:1161-1180.
70. Mirra S.S. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiol. Aging 1997, 18(4 Suppl):S91-S94.
71. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
72. Mitchell T.W., Mufson E.J., Schneider J.A., Cochran E.J., Nissanov J., Han L.Y., Bienias J.L., Lee V.M., Trojanowski J.Q., Bennett D.A., Arnold S.E. Parahippocampal tau pathology in healthy aging, mild cognitive impairment, and early Alzheimer's disease. Ann. Neurol. 2002, 51:182-189.
73. Montine K.S., Reich E., Neely M.D., Sidell K.R., Olson S.J., Markesbery W.R., Montine T.J. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype. J. Neuropathol. Exp. Neurol. 1998, 57:415-425.
74. Morris J.C., Price J.L. Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. J. Mol. Neurosci. 2001, 17:101-118.
75. Mota S.I., Costa R.O., Ferreira I.L., Santana I., Caldeira G.L., Padovano C., Fonseca A.C., Baldeiras I., Cunha C., Letra L., Oliveira C.R., Pereira C.M., Rego A.C. Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease. Biochim. Biophys. Acta 2015, 1852:1428-1441.
76. Mufson E.J., Binder L., Counts S.E., DeKosky S.T., de Toledo-Morrell L., Ginsberg S.D., Ikonomovic M.D., Perez S.E., Scheff S.W. Mild cognitive impairment: pathology and mechanisms. Acta Neuropathol. 2012, 123:13-30.
77. Mufson E.J., Chen E.Y., Cochran E.J., Beckett L.A., Bennett D.A., Kordower J.H. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp. Neurol. 1999, 158:469-490.
78. Mufson E.J., Ma S.Y., Cochran E.J., Bennett D.A., Beckett L.A., Jaffar S., Saragovi H.U., Kordower J.H. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J. Comp. Neurol. 2000, 427:19-30.
79. Mufson E.J., Mahady L., Waters D., Counts S.E., Perez S.E., DeKosky S.T., Ginsberg S.D., Ikonomovic M.D., Scheff S.W., Binder L.I. Hippocampal plasticity during the progression of Alzheimer's disease. Neuroscience 2015, 309:51-67.
80. Mufson E.J., Malek-ahmadi M., Perez S.E., Chen K. Braak staging, plaque pathology, and APOE status in elderly persons without cognitive impairment. Neurobiol. Aging 2016, 37:147-153.
81. Murphy M.P., Beckett T.L., Ding Q., Patel E., Markesbery W.R., St Clair D.K., LeVine H., Keller J.N. Abeta solubility and deposition during AD progression and in APPxPS-1 knock-in mice. Neurobiol. Dis. 2007, 27:301-311.
82. Nag S., Yu L., Capuano A.W., Wilson R.S., Leurgans S.E., Bennett D.A., Schneider J.A. Hippocampal sclerosis and TDP-43 pathology in aging and Alzheimer disease. Ann. Neurol. 2015, 77:942-952.
83. Nelson P.T., Abner E.L., Schmitt F.A., Kryscio R.J., Jicha G.A., Santacruz K., Smith C.D., Patel E., Markesbery W.R. Brains with medial temporal lobe neurofibrillary tangles but no neuritic amyloid plaques are a diagnostic dilemma but may have pathogenetic aspects distinct from Alzheimer disease. J. Neuropathol. Exp. Neurol. 2009, 68:774-784.
84. Nelson P.T., Alafuzoff I., Bigio E.H., Bouras C., Braak H., Cairns N.J., Castellani R.J., Crain B.J., Davies P., Del Tredici K., Duyckaerts C., Frosch M.P., Haroutunian V., Hof P.R., Hulette C.M., Hyman B.T., Iwatsubo T., Jellinger K.A., Jicha G.A., Kovari E., Kukull W.A., Leverenz J.B., Love S., Mackenzie I.R., Mann D.M., Masliah E., McKee A.C., Montine T.J., Morris J.C., Schneider J.A., Sonnen J.A., Thal D.R., Trojanowski J.Q., Troncoso J.C., Wisniewski T., Woltjer R.L., Beach T.G. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J. Neuropathol. Exp. Neurol. 2012, 71:362-381.
85. Nelson P.T., Schmitt F.A., Lin Y., Abner E.L., Jicha G.A., Patel E., Thomason P.C., Neltner J.H., Smith C.D., Santacruz K.S., Sonnen J.A., Poon L.W., Gearing M., Green R.C., Woodard J.L., Van Eldik L.J., Kryscio R.J. Hippocampal sclerosis in advanced age: clinical and pathological features. Brain 2011, 134(Pt 5):1506-1518.
86. Nelson P.T., Smith C.D., Abner E.L., Wilfred B.J., Wang W.X., Neltner J.H., Baker M., Fardo D.W., Kryscio R.J., Scheff S.W., Jicha G.A., Jellinger K.A., Van Eldik L.J., Schmitt F.A. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease. Acta Neuropathol. 2013, 126:161-177.
87. Neltner J.H., Abner E.L., Baker S., Schmitt F.A., Kryscio R.J., Jicha G.A., Smith C.D., Hammack E., Kukull W.A., Brenowitz W.D., Van Eldik L.J., Nelson P.T. Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing. Brain 2014, 137(Pt 1):255-267.
88. Noda K., Sasaki K., Fujimi K., Wakisaka Y., Tanizaki Y., Wakugawa Y., Kiyohara Y., Iida M., Aizawa H., Iwaki T. Quantitative analysis of neurofibrillary pathology in a general population to reappraise neuropathological criteria for senile dementia of the neurofibrillary tangle type (tangle-only dementia): the Hisayama Study. Neuropathology 2006, 26:508-518.
89. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E.K., Jones P.K., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C.S., Petersen R.B., Smith M.A. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2001, 60:759-767.
90. Picard M. Mitochondrial synapses: intracellular communication and signal integration. Trends Neurosci. 2015, 38:468-474.
91. Pratico D., Sung S. Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J. Alzheimer's Dis. 2004, 6:171-175.
92. Price J.L., Davis P.B., Morris J.C., White D.L. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging 1991, 12:295-312.
93. Price J.L., McKeel D.W., Buckles V.D., Roe C.M., Xiong C., Grundman M., Hansen L.A., Petersen R.C., Parisi J.E., Dickson D.W., Smith C.D., Davis D.G., Schmitt F.A., Markesbery W.R., Kaye J., Kurlan R., Hulette C., Kurland B.F., Higdon R., Kukull W., Morris J.C. Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol. Aging 2009, 30:1026-1036.
94. Roberts R.C., Barksdale K.A., Roche J.K., Lahti A.C. Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia. Schizophr. Res. 2015, 168:543-553.
95. Salminen A., Haapasalo A., Kauppinen A., Kaarniranta K., Soininen H., Hiltunen M. Impaired mitochondrial energy metabolism in Alzheimer's disease: impact on pathogenesis via disturbed epigenetic regulation of chromatin landscape. Prog. Neurobiol. 2015, 131:1-20.
96. SantaCruz K.S., Sonnen J.A., Pezhouh M.K., Desrosiers M.F., Nelson P.T., Tyas S.L. Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the nun study and the adult changes in thought study. J. Neuropathol. Exp. Neurol. 2011, 70:832-840.
97. Scheff S.W., Ginsberg S.D., Counts S.E., Mufson E.J. Synaptic integrity in mild cognitive impairment and Alzheimer's disease. Research Progress in Alzheimer's Disease and Dementia (V) 2012, 23-49. Nova Science Publishers, New York. M.K. Sun (Ed.).
98. Scheff S.W., Neltner J.H., Nelson P.T. Is synaptic loss a unique hallmark of Alzheimer's disease?. Biochem. Pharmacol. 2014, 88:517-528.
99. Scheff S.W., Price D.A. Alzheimer's disease-related alterations in synaptic density: neocortex and hippocampus. J. Alzheimer's Dis. 2006, 9(3 Suppl):101-115.
100. Scheff S.W., Price D.A., Ansari M.A., Roberts K.N., Schmitt F.A., Ikonomovic M.D., Mufson E.J. Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease. J. Alzheimer's Dis. 2015, 43:1073-1090.
101. Scheff S.W., Price D.A., Schmitt F.A., DeKosky S.T., Mufson E.J. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 2007, 68:1501-1508.
102. Scheff S.W., Price D.A., Schmitt F.A., Mufson E.J. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 2006, 27:1372-1384.
103. Scheff S.W., Price D.A., Schmitt F.A., Scheff M.A., Mufson E.J. Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. J. Alzheimer's Dis. 2011, 24:547-557.
104. Schmitt F.A., Davis D.G., Wekstein D.R., Smith C.D., Ashford J.W., Markesbery W.R. "Preclinical" AD revisited: neuropathology of cognitively normal older adults. Neurology 2000, 55:370-376.
105. Schmitt F.A., Nelson P.T., Abner E., Scheff S., Jicha G.A., Smith C., Cooper G., Mendiondo M., Danner D.D., Van Eldik L.J., Caban-Holt A., Lovell M.A., Kryscio R.J. University of Kentucky Sanders-Brown healthy brain aging volunteers: donor characteristics, procedures and neuropathology. Curr. Alzheimer Res. 2012, 9:724-733.
106. Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., Farrell M.A., Rowan M.J., Lemere C.A., Regan C.M., Walsh D.M., Sabatini B.L., Selkoe D.J. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 2008, 14:837-842.
107. Simoncini C., Orsucci D., Caldarazzo Ienco E., Siciliano G., Bonuccelli U., Mancuso M. Alzheimer's pathogenesis and its link to the mitochondrion. Oxid. Med. Cell. Longev. 2015, 2015:803942. 1-8.
108. Sperling R.A., Aisen P.S., Beckett L.A., Bennett D.A., Craft S., Fagan A.M., Iwatsubo T., Jack C.R., Kaye J., Montine T.J., Park D.C., Reiman E.M., Rowe C.C., Siemers E., Stern Y., Yaffe K., Carrillo M.C., Thies B., Morrison-Bogorad M., Wagster M.V., Phelps C.H. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's Dement. 2011, 7:280-292.
109. Stamer K., Vogel R., Thies E., Mandelkow E., Mandelkow E.M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell Biol. 2002, 156:1051-1063.
110. Stern Y. Cognitive reserve. Neuropsychologia 2009, 47:2015-2028.
111. Sultana R., Banks W.A., Butterfield D.A. Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease. J. Neurosci. Res. 2010, 88:469-477.
112. Swerdlow R.H., Burns J.M., Khan S.M. The Alzheimer's disease mitochondrial cascade hypothesis: progress and perspectives. Biochim. Biophys. Acta 2014, 1842:1219-1231.
113. Swerdlow R.H., Khan S.M. A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease. Med. Hypotheses 2004, 63:8-20.
114. Sze C.I., Troncoso J.C., Kawas C., Mouton P., Price D.L., Martin L.J. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J. Neuropathol. Exp. Neurol. 1997, 56:933-944.
115. Takahashi R.H., Capetillo-Zarate E., Lin M.T., Milner T.A., Gouras G.K. Co-occurrence of Alzheimer's disease ss-amyloid and tau pathologies at synapses. Neurobiol. Aging 2010, 31:1145-1152.
116. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 1991, 30:572-580.
117. Tomlinson B.E., Blessed G., Roth M. Observations on the brains of non-demented old people. J. Neurol. Sci. 1968, 7:331-356.
118. Townsend M., Shankar G.M., Mehta T., Walsh D.M., Selkoe D.J. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 2006, 572(Pt 2):477-492.
119. Troncoso J.C., Cataldo A.M., Nixon R.A., Barnett J.L., Lee M.K., Checler F., Fowler D.R., Smialek J.E., Crain B., Martin L.J., Kawas C.H. Neuropathology of preclinical and clinical late-onset Alzheimer's disease. Ann. Neurol. 1998, 43:673-676.
120. Troncoso J.C., Martin L.J., Dal Forno G., Kawas C.H. Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging. Neurobiol. Aging 1996, 17:365-371.
121. Volgyi K., Gulyassy P., Haden K., Kis V., Badics K., Kekesi K.A., Simor A., Gyorffy B., Toth E.A., Lubec G., Juhasz G., Dobolyi A. Synaptic mitochondria: a brain mitochondria cluster with a specific proteome. J. Proteomics 2015, 120:142-157.
122. Walsh D.M., Selkoe D.J. A beta oligomers - a decade of discovery. J. Neurochem. 2007, 101:1172-1184.
123. Wang X., Su B., Siedlak S.L., Moreira P.I., Fujioka H., Wang Y., Casadesus G., Zhu X. Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:19318-19323.
124. Wang X., Wang W., Li L., Perry G., Lee H.G., Zhu X. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim. Biophys. Acta 2014, 1842:1240-1247.
125. Williams D.R. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau. Intern. Med. J. 2006, 36:652-660.
126. Williams T.I., Lynn B.C., Markesbery W.R., Lovell M.A. Increased levels of 4-hydroxynonenal and acrolein, neurotoxic markers of lipid peroxidation, in the brain in mild cognitive impairment and early Alzheimer's disease. Neurobiol. Aging 2006, 27:1094-1099.
127. Yan M.H., Wang X., Zhu X. Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Radic. Biol. Med. 2013, 62:90-101.
128. Yu L., Chibnik L.B., Srivastava G.P., Pochet N., Yang J., Xu J., Kozubek J., Obholzer N., Leurgans S.E., Schneider J.A., Meissner A., De Jager P.L., Bennett D.A. Association of Brain DNA methylation in SORL1, ABCA7, HLA-DRB5, SLC24A4, and BIN1 with pathological diagnosis of Alzheimer disease. JAMA Neurol. 2015, 72:15-24.
129. Zhang H.Y., Wang Z.G., Lu X.H., Kong X.X., Wu F.Z., Lin L., Tan X., Ye L.B., Xiao J. Endoplasmic reticulum stress: relevance and therapeutics in central nervous system diseases. Mol. Neurobiol. 2015, 51:1343-1352.
130. Zhao Y., Zhao B. Oxidative stress and the pathogenesis of Alzheimer's disease. Oxid. Med. Cell. Longev. 2013, 2013:316523.